Catherine Guerreiro
CNRS UMR3523, 28 Rue Du Dr Roux, 75724 Paris Cedex 15
Paris, 75724, France
Paris, 75724, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against Shigella.
Journal: ACS central science
Published: December 01, 2021
Dirhamnolipids secreted from Pseudomonas aeruginosa modify anjpegungal susceptibility of Aspergillus fumigatus by inhibiting β1,3 glucan synthase activity.
Journal: The ISME journal
Published: November 03, 2016
A Synthetic Carbohydrate Conjugate Vaccine Candidate against Shigellosis: Improved Bioconjugation and Impact of Alum on Immunogenicity.
Journal: Bioconjugate chemistry
Published: February 27, 2016
Detailed Investigation of the Immunodominant Role of O-Antigen Stoichiometric O-Acetylation as Revealed by Chemical Synthesis, Immunochemistry, Solution Conformation and STD-NMR Spectroscopy for Shigella flexneri 3a.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: February 05, 2016
Programmed chemo-enzymatic synthesis of the oligosaccharide component of a carbohydrate-based antibacterial vaccine candidate.
Journal: Chemical communications (Cambridge, England)
Published: January 09, 2015
Linear synthesis of the branched pentasaccharide repeats of O-antigens from Shigella flexneri 1a and 1b demonstrating the major steric hindrance associated with type-specific glucosylation.
Journal: Organic & biomolecular chemistry
Published: August 22, 2014
Non-stoichiometric O-acetylation of Shigella flexneri 2a O-specific polysaccharide: synthesis and antigenicity.
Journal: Organic & biomolecular chemistry
Published: May 20, 2014
CGTase-catalysed cis-glucosylation of L-rhamnosides for the preparation of Shigella flexneri 2a and 3a haptens.
Journal: Chembiochem : a European journal of chemical biology
Published: September 16, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026